Inventor · disambiguated record
Christopher John Yarnold
Also filed as: YARNOLD CHRISTOPHER · YARNOLD CHRISTOPHER J · YARNOLD CHRISTOPHER JOHN
14 granted patents·11 pending applications·64 citations·filing 1998–2023
89Inventor score
Top patents by PatentIndex Score
25 records- 0190US10364239B2Ferroportin inhibitorsVIFOR INT AG·Filed 2016·Granted Jul 30, 2019·6 cites·21 claims
- 0284US10738041B2Ferroportin inhibitorsVIFOR (INTERNATIONAL) AG·Filed 2016·Granted Aug 11, 2020·3 cites·18 claims
- 0384US8536186B2Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereofWITYAK JOHN·Filed 2009·Granted Sep 17, 2013·9 cites·6 claims
- 0482US9145373B2Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereofWITYAK JOHN·Filed 2013·Granted Sep 29, 2015·7 cites·9 claims
- 0573US6573247B1Anti-viral pyrimidine nucleoside analoguesUNIV CARDIFF·Filed 1998·Granted Jun 3, 2003·36 cites·14 claims
- 0672US11066399B2Ferroportin inhibitorsVIFOR INT AG·Filed 2020·Granted Jul 20, 2021·0 cites·6 claims
- 0771US2022363675A1Novel Ferroportin InhibitorsVIFOR INT AG·Filed 2021·Application pending·0 cites
- 0869US8946197B2Transglutaminase TG2 inhibitors, pharmaceutical compositions, and methods of use thereofDOMINGUEZ CELIA·Filed 2010·Granted Feb 3, 2015·1 cites·50 claims
- 0968US11001579B2Ferroportin inhibitorsVIFOR INT AG·Filed 2019·Granted May 11, 2021·0 cites·11 claims
- 1064US9102688B2Sulfonaminoquinoline hepcidin antagonistsVIFOR INT AG·Filed 2014·Granted Aug 11, 2015·1 cites·16 claims
- 1158US7915304B2Phenyl substituted maleimides as medicaments for blocking degenerative tissue damages by inhibiting MPTCONGENIA S R L·Filed 2007·Granted Mar 29, 2011·1 cites·17 claims
- 1258US2022356148A1Antiviral compoundsHAPLOGEN GMBH·Filed 2021·Application pending·0 cites
- 1355US2025289793A1Macrocyclic inhibitors of atp citrate lyaseESPERION THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1452US2011230428A1Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereofWITYAK JOHN·Filed 2009·Application pending·0 cites
- 1550US8691824B2Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereofWITYAK JOHN·Filed 2009·Granted Apr 8, 2014·0 cites·20 claims
- 1647US2022127232A1Histone acetyltransferase modulators and compositions and uses thereofUNIV COLUMBIA·Filed 2020·Application pending·0 cites
- 1746US11091428B2Antiviral compoundsHAPLOGEN GMBH·Filed 2017·Granted Aug 17, 2021·0 cites·3 claims
- 1846US2006235012A1Carboline and betacarboline derivatives for use as hdac enzyme inhibitorsCHROMA THERAPEUTICS LTD·Filed 2004·Application pending·0 cites
- 1941US2015232420A1Transglutaminase tg2 inhibitors, pharmaceutical compositions, and methods of use thereofDOMINGUEZ CELIA·Filed 2013·Application pending·0 cites
- 2038US2008194574A1Pyrazine Derivatives As Effective Compounds Against Infectious DiseasesAXXIMA PHARMACEUTICALS AG·Filed 2004·Application pending·0 cites
- 2137US8592430B2Quinazolin-oxime derivatives as Hsp90 inhibitorsCOURTNEY STEPHEN MARTIN·Filed 2008·Granted Nov 26, 2013·0 cites·21 claims
- 2233US11180479B2Antiviral compoundsHAPLOGEN GMBH·Filed 2018·Granted Nov 23, 2021·0 cites·16 claims
- 2328US2012202806A1Novel Pyrimidine- And Triazine-Hepcidine AntagonistsDUERRENBERGER FRANZ·Filed 2010·Application pending·0 cites
- 2428US2012214798A1Novel Ethanediamone Hepcidine AntagonistsDUERRENBERGER FRANZ·Filed 2010·Application pending·0 cites
- 2527US2012196853A1Novel Quinoline-Hepcidine AntagonistsDUERRENBERGER FRANZ·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →